CN Patent

CN1874996B — 氨基丙醇衍生物

Assigned to Novartis AG · Expires 2011-05-18 · 15y expired

What this patent protects

式(I)化合物、它们的生产方法、它们的用途和含有它们的药物组合物，其中R 1 、R 2 、n和m如说明书所定义。

USPTO Abstract

式(I)化合物、它们的生产方法、它们的用途和含有它们的药物组合物，其中R 1 、R 2 、n和m如说明书所定义。

Drugs covered by this patent

Patent Metadata

Patent number
CN1874996B
Jurisdiction
CN
Classification
—
Expires
2011-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.